» Articles » PMID: 17943229

Hepatitis C Virus Infection in Italian Patients with Fibromyalgia

Overview
Journal Clin Rheumatol
Publisher Springer
Specialty Rheumatology
Date 2007 Oct 19
PMID 17943229
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

We evaluated the prevalence of hepatitis C virus (HCV) infection in Italian patients suffering from fibromyalgia (FM), in comparison with patients affected by non-HCV related rheumatic degenerative disorders. Consecutive patients with FM and a statistically comparable group of patients suffering from peripheral osteoarthritis (OA) or sciatica due to L4-L5 or L5-S1 herniated disc were tested for HCV infection with a third-generation microparticle enzyme immunoassay (MEIA). In the positive cases, a third-generation recombinant immunoblot assay (RIBA) confirmatory test and serum HCV-RNA test were performed. Fisher's exact test was performed to compare the prevalence of HCV infection (MEIA- and RIBA-positive results) obtained in the two enrolled groups. Enrolled were 152 subjects suffering from FM and 152 patients with peripheral OA or sciatica. Anti-HCV antibodies were found in 7/152 (4.6%) patients suffering from FM and in 5/152 (3.3%) of control subjects. No statistically significant differences in HCV prevalence were detected between cases and controls. Our present report does not confirm previous data indicating an increased prevalence of HCV in FM patients and does not seem to support a significant pathogenetic role of HCV under this condition.

Citing Articles

A Review on Extrahepatic Manifestations of Chronic Hepatitis C Virus Infection and the Impact of Direct-Acting Antiviral Therapy.

Mazzaro C, Quartuccio L, Adinolfi L, Roccatello D, Pozzato G, Nevola R Viruses. 2021; 13(11).

PMID: 34835054 PMC: 8619859. DOI: 10.3390/v13112249.


Are the testing needs of key European populations affected by hepatitis B and hepatitis C being addressed? A scoping review of testing studies in Europe.

Lazarus J, Sperle I, Spina A, Rockstroh J Croat Med J. 2016; 57(5):442-456.

PMID: 27815935 PMC: 5141462. DOI: 10.3325/cmj.2016.57.442.


Rheumatic manifestations of hepatitis C virus chronic infection: Indications for a correct diagnosis.

Palazzi C, DAmico E, DAngelo S, Gilio M, Olivieri I World J Gastroenterol. 2016; 22(4):1405-10.

PMID: 26819509 PMC: 4721975. DOI: 10.3748/wjg.v22.i4.1405.


Measuring the response of extrahepatic symptoms and quality of life to antiviral treatment in patients with hepatitis C.

Isaacs D, Abdelaziz N, Keller M, Tibble J, Haq I Hepat Res Treat. 2013; 2013:910519.

PMID: 24223303 PMC: 3816051. DOI: 10.1155/2013/910519.


The prevalence of fibromyalgia among patients with hepatitis B virus infection.

Ozsahin M, Gonen I, Ermis F, Oktay M, Besir F, Kutlucan A Int J Clin Exp Med. 2013; 6(9):804-8.

PMID: 24179575 PMC: 3798217.


References
1.
Narvaez J, Nolla J, Valverde-Garcia J . Lack of association of fibromyalgia with hepatitis C virus infection. J Rheumatol. 2005; 32(6):1118-21. View

2.
Campello C, Poli A, Dal M . Seroprevalence, viremia and genotype distribution of hepatitis C virus: a community-based population study in northern Italy. Infection. 2002; 30(1):7-12. DOI: 10.1007/s15010-001-1197-4. View

3.
Kozanoglu E, Canataroglu A, Abayli B, Colakoglu S, Goncu K . Fibromyalgia syndrome in patients with hepatitis C infection. Rheumatol Int. 2003; 23(5):248-51. DOI: 10.1007/s00296-003-0290-7. View

4.
Wolfe F, Smythe H, Yunus M, Bennett R, Bombardier C, Goldenberg D . The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum. 1990; 33(2):160-72. DOI: 10.1002/art.1780330203. View

5.
Rivera J, de Diego A, Trinchet M, Garcia Monforte A . Fibromyalgia-associated hepatitis C virus infection. Br J Rheumatol. 1997; 36(9):981-5. DOI: 10.1093/rheumatology/36.9.981. View